IMRT 2018
Background for high dose RT with concurrent CT
Phase I and II Trials establishing safety and potential efficacy of 74 Gy delivered using 3D-Conformal Radiation Therapy
Study
Radiation dose (Gy)
Chemotherapy
Median survival time (months)
RTOG 0117
74
Carboplatin/paclitaxel
21.6
NCCTG 0028
74
Carboplatin/paclitaxel
37
North Carolina
74
Carboplatin/paclitaxel
24
Wake Forest
74
Gemcitabine
18
CALGB 30105
74
Carboplatin/paclitaxel
24
Made with FlippingBook - professional solution for displaying marketing and sales documents online